PROM1 and breast cancer: In this study, we isolated human CD133+ HPCs and CD133- cells from human UCB and tested whether CD133+ HPCs modulated the malignancy of breast cancer cells in vitro and in vivo to explore the potential mechanisms involved in metastasis.